The Desimone Levee on the Green River failed and is under repair. The hospital is above the flood zone and currently in no danger of flooding. We evacuated our Time Square and Kent Station Clinics and our Lind Avenue locations. Several locations are experiencing staffing issues due to severe traffic impacts. Impacted patients are being contacted to reschedule appointments. Please be safe, do not drive or walk through standing water, and call 9-1-1 if you need emergency evacuation assistance.
Click here for King County Road Closure Real-time Tracker.
Provider Recognition Corner - July 2019
Robert Douglas, MD
June Provider of the Month
Congratulations to Dr. Robert Douglas, of Valley's Radiation Oncology clinic. Dr. Douglas is a compassionate man who cares deeply for his patients and his teammates. He is known for always going above and beyond, and has been actively involved in fundraising for Valley's new Cancer Center. But perhaps the best way to showcase Dr. Douglas' compassionate care is through the words of a patient. Below is a letter from Evelyn Butler, who was a Valley employee and a patient of Dr. Douglas':
“I was so surprised when I received a call yesterday out of the blue from Dr. Douglas, taking the time out of his busy schedule to pick up the phone and reach out to me. He took the time to answer all of my questions, several which were repeats, explain the status of the insurance authorization, and reminded me that all treatment plans are ultimately up to me. I was really impressed. He was very patient, compassionate, and listened. You have a good one here, I am so proud to be a part of such a wonderful organization. ‘We are Valley - Patients are First‘ – he reminded me why we're all here and that it's not just a tagline but is practiced by our providers.
Neurosciences Research and Publication
David Vossler, MD, and VMC’s Neuroscience Institute just published new research in the July 2019 issue of Epilepsia (official journal of the International League Against Epilepsy).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/epi.16069
Dr. Vossler and medical assistant, Katie Mayhew, recruited Valley Epilepsy Center patients into the eslicarbazepine 304 study (as add-on therapy to other antiepileptic drugs) and into the subsequent eslicarbazepine 045 monotherapy study (their existing AEDs were stopped once they were on eslicarbazepine). These were two of the five research studies that led to approval of the drug for add-on and for monotherapy, as well as used in this new analysis.
Dr. Vossler noted, “Until 2019 our patients had to go to an off-site research center. Now, we have a new Research Center at VMC with Dione Froman and Shannon Huffaker, RN running it with participating physicians like Dr. Navanshu Arora and me. Gayle Jewett is the administrator over VMC Clinical Research Center.”